vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and ENERGY FUELS INC (UUUU). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $27.1M, roughly 1.7× ENERGY FUELS INC). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -77.3%, a 57.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -32.1%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 98.7%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

FuelCell Energy, Inc. is a publicly traded fuel cell company headquartered in Danbury, Connecticut. It designs, manufactures, operates and services power plants based on molten carbonate fuel cells.

ABCL vs UUUU — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.7× larger
ABCL
$44.9M
$27.1M
UUUU
Growing faster (revenue YoY)
ABCL
ABCL
+820.5% gap
ABCL
788.4%
-32.1%
UUUU
Higher net margin
ABCL
ABCL
57.3% more per $
ABCL
-19.9%
-77.3%
UUUU
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
98.7%
UUUU

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
UUUU
UUUU
Revenue
$44.9M
$27.1M
Net Profit
$-8.9M
$-20.9M
Gross Margin
35.0%
Operating Margin
-63.7%
-81.6%
Net Margin
-19.9%
-77.3%
Revenue YoY
788.4%
-32.1%
Net Profit YoY
73.9%
36.5%
EPS (diluted)
$-0.03
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
UUUU
UUUU
Q4 25
$44.9M
$27.1M
Q3 25
$9.0M
$17.7M
Q2 25
$17.1M
Q1 25
$4.2M
$16.9M
Q4 24
$5.0M
$39.9M
Q3 24
$6.5M
Q2 24
$7.3M
$8.7M
Q1 24
$10.0M
$25.4M
Net Profit
ABCL
ABCL
UUUU
UUUU
Q4 25
$-8.9M
$-20.9M
Q3 25
$-57.1M
$-16.7M
Q2 25
$-34.7M
Q1 25
$-45.6M
$-26.3M
Q4 24
$-33.0M
Q3 24
$-51.1M
Q2 24
$-36.9M
$-6.4M
Q1 24
$-40.6M
$3.6M
Gross Margin
ABCL
ABCL
UUUU
UUUU
Q4 25
35.0%
Q3 25
27.8%
Q2 25
Q1 25
-7.3%
Q4 24
1.5%
Q3 24
Q2 24
57.8%
Q1 24
56.5%
Operating Margin
ABCL
ABCL
UUUU
UUUU
Q4 25
-63.7%
-81.6%
Q3 25
-851.8%
-150.6%
Q2 25
-290.2%
Q1 25
-1479.6%
-155.0%
Q4 24
-71.6%
Q3 24
-1439.4%
Q2 24
-1276.2%
-103.7%
Q1 24
-551.5%
7.9%
Net Margin
ABCL
ABCL
UUUU
UUUU
Q4 25
-19.9%
-77.3%
Q3 25
-637.8%
-94.5%
Q2 25
-203.3%
Q1 25
-1077.2%
-155.6%
Q4 24
-82.6%
Q3 24
-785.4%
Q2 24
-504.3%
-73.6%
Q1 24
-408.0%
14.3%
EPS (diluted)
ABCL
ABCL
UUUU
UUUU
Q4 25
$-0.03
$-0.08
Q3 25
$-0.19
$-0.07
Q2 25
$-0.12
Q1 25
$-0.15
$-0.13
Q4 24
$-0.19
Q3 24
$-0.17
Q2 24
$-0.13
$-0.04
Q1 24
$-0.14
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
UUUU
UUUU
Cash + ST InvestmentsLiquidity on hand
$128.5M
$64.7M
Total DebtLower is stronger
$675.7M
Stockholders' EquityBook value
$966.9M
$678.4M
Total Assets
$1.4B
$1.4B
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
UUUU
UUUU
Q4 25
$128.5M
$64.7M
Q3 25
$83.2M
$94.0M
Q2 25
$92.4M
Q1 25
$159.3M
$73.0M
Q4 24
$156.3M
$38.6M
Q3 24
$126.6M
Q2 24
$148.3M
$24.6M
Q1 24
$123.6M
$54.8M
Total Debt
ABCL
ABCL
UUUU
UUUU
Q4 25
$675.7M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ABCL
ABCL
UUUU
UUUU
Q4 25
$966.9M
$678.4M
Q3 25
$964.0M
$703.2M
Q2 25
$1.0B
Q1 25
$1.0B
$580.8M
Q4 24
$1.1B
$527.8M
Q3 24
$1.1B
Q2 24
$1.1B
$378.8M
Q1 24
$1.1B
$383.7M
Total Assets
ABCL
ABCL
UUUU
UUUU
Q4 25
$1.4B
$1.4B
Q3 25
$1.4B
$758.3M
Q2 25
$1.4B
Q1 25
$1.3B
$650.8M
Q4 24
$1.4B
$612.0M
Q3 24
$1.4B
Q2 24
$1.4B
$403.4M
Q1 24
$1.5B
$405.8M
Debt / Equity
ABCL
ABCL
UUUU
UUUU
Q4 25
1.00×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
UUUU
UUUU
Operating Cash FlowLast quarter
$-34.7M
$-16.2M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
UUUU
UUUU
Q4 25
$-34.7M
$-16.2M
Q3 25
$-52.6M
$-28.5M
Q2 25
$-32.4M
Q1 25
$-11.6M
$-18.8M
Q4 24
$-108.6M
$-36.0M
Q3 24
$-28.9M
Q2 24
$-30.0M
$-9.7M
Q1 24
$-41.7M
$8.8M
Free Cash Flow
ABCL
ABCL
UUUU
UUUU
Q4 25
$-44.6M
Q3 25
$-61.5M
Q2 25
$-45.8M
Q1 25
$-22.2M
Q4 24
$-187.0M
Q3 24
$-47.4M
Q2 24
$-50.1M
Q1 24
$-65.8M
FCF Margin
ABCL
ABCL
UUUU
UUUU
Q4 25
-99.4%
Q3 25
-687.0%
Q2 25
-267.9%
Q1 25
-524.0%
Q4 24
-3702.8%
Q3 24
-728.4%
Q2 24
-683.8%
Q1 24
-661.5%
Capex Intensity
ABCL
ABCL
UUUU
UUUU
Q4 25
21.9%
Q3 25
99.7%
Q2 25
78.2%
Q1 25
251.1%
Q4 24
1552.7%
Q3 24
284.6%
Q2 24
274.6%
Q1 24
242.5%
Cash Conversion
ABCL
ABCL
UUUU
UUUU
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
2.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons